CGEN
Compugen (CGEN)
$52
About Compugen (CGEN)
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Details
Daily high
$1.66
Daily low
$1.47
Price at open
$1.66
52 Week High
$2.66
52 Week Low
$1.13
Market cap
139.4M
Dividend yield
0.00%
Volume
567,002
Avg. volume
282,569
P/E ratio
-4.98
Compugen News
Details
Daily high
$1.66
Daily low
$1.47
Price at open
$1.66
52 Week High
$2.66
52 Week Low
$1.13
Market cap
139.4M
Dividend yield
0.00%
Volume
567,002
Avg. volume
282,569
P/E ratio
-4.98